Details for Patent: 9,126,931
✉ Email this page to a colleague
Which drugs does patent 9,126,931 protect, and when does it expire?
Patent 9,126,931 protects ALECENSA and is included in one NDA.
This patent has seventy-two patent family members in thirty-nine countries.
Summary for Patent: 9,126,931
| Title: | Tetracyclic compound |
| Abstract: | A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder: ##STR00001## (meanings of the symbols that are included in the formula are as given in the specification). |
| Inventor(s): | Kinoshita; Kazutomo (Kanagawa, JP), Asoh; Kohsuke (Kanagawa, JP), Furuichi; Noriyuki (Kanagawa, JP), Ito; Toshiya (Kanagawa, JP), Kawada; Hatsuo (Kanagawa, JP), Ishii; Nobuya (Kanagawa, JP), Sakamoto; Hiroshi (Kanagawa, JP), Hong; WooSang (Gyeonggi-do, KR), Park; MinJeong (Gyeonggi-do, KR), Ono; Yoshiyuki (Shizuoka, JP), Kato; Yasuharu (Shizuoka, JP), Morikami; Kenji (Shizuoka, JP), Emura; Takashi (Shizuoka, JP), Oikawa; Nobuhiro (Kanagawa, JP) |
| Assignee: | Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) |
| Application Number: | 13/377,300 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 9,126,931
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | 9,126,931 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,126,931
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2009-139691 | Jun 10, 2009 |
| PCT Information | |||
| PCT Filed | June 09, 2010 | PCT Application Number: | PCT/JP2010/059785 |
| PCT Publication Date: | December 16, 2010 | PCT Publication Number: | WO2010/143664 |
International Family Members for US Patent 9,126,931
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2441753 | ⤷ Subscribe | 300876 | Netherlands | ⤷ Subscribe |
| European Patent Office | 2441753 | ⤷ Subscribe | CA 2017 00024 | Denmark | ⤷ Subscribe |
| European Patent Office | 2441753 | ⤷ Subscribe | PA2017017 | Lithuania | ⤷ Subscribe |
| European Patent Office | 2441753 | ⤷ Subscribe | 122017000048 | Germany | ⤷ Subscribe |
| European Patent Office | 2441753 | ⤷ Subscribe | CR 2017 00024 | Denmark | ⤷ Subscribe |
| European Patent Office | 2441753 | ⤷ Subscribe | 1790024-2 | Sweden | ⤷ Subscribe |
| European Patent Office | 2441753 | ⤷ Subscribe | LUC00022 | Luxembourg | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
